MVA-BN IMVAMUNE Smallpox Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVA-BN IMVAMUNE Smallpox Vaccine, covering 2019-01-09 to 2019-01-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis [Phase 2]